How much will a box of Opicapone cost in the market in 2025?

Opicapone is a drug used to treat Parkinson's disease. Its main function is as a peripheral tyrosine hydroxylase inhibitor to increase the availability of dopamine, thereby improving the patient's motor symptoms. Although Opicapone has been launched in some countries and has achieved good clinical results, as of 2025, it has not yet been officially launched in the Chinese market, which makes many patients who need this drug face financial challenges.

In Europe, the original version of Opicapone has been widely used, and each box of 90 50mg pills sells for about 2,000 yuan. Because drug prices are often affected by factors such as exchange rates, production costs, and market demand, prices may fluctuate. In China, no generic version of Opicapone has yet entered the market, which means patients can only rely on imported drugs, which are usually more expensive, putting pressure on patients' financial burden.

For patients who rely on Opicapone for treatment, the lack of drugs and high prices undoubtedly make their treatment more difficult. This not only affects the patient's quality of life, but in some cases may even lead to the patient's inability to adhere to an effective treatment plan. While other drugs for Parkinson's disease exist on the market, not every drug meets the needs of all patients. Therefore, the absence of opicapone further limits patient options.

In order to solve this problem, it is expected that more generic drugs will enter the market in the future, providing more competitive prices and choices. In addition, with the rapid development of China's pharmaceutical industry, more and more innovative drugs and generic drugs are expected to be approved and put on the market in the near future. By then, patients will have more treatment options and treatment costs may also be reduced.

Reference materials:https://www.ongentys.com/